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= –0.053, NS). These results suggest that in post-infarction patients with
reduced LVEF,heart rate variability is mainly determined by the sympathetic
overdrive caused by the loss of left ventricular performance which masks the
physiologic influence of age.
m980147 Anti-ischemicEfficacyof Beta-blockerainEffortAnainaPatientsisCorrelatedwithHeartRate. ....
VariabilityChangeAfter Therapy
T. Kaji, T. Kohya, F.Tomita, T. One, Y. Itoh, A, Kitabatake. Dept. of
Cardiovascular Medicine, Hokkaido University School of Medicine,
Sepporo, Japan
Although it is reported that reduced heart rate variability (HRV) predicts pca
prognosis in patients (pts) with coronary artery disease, Iittledata iaavailable
about the effects of antianginal drugs on HRV. The aim of this study is
to compare the effects of various antianginal drugs on autonomic nervous
activity in pts with effort angina (EA) using ambulatory ECG monitoring (AEM)
and analysie of HRV. Forty-four pts with EA (55 + 9 years) were allocated to
3 treatment groups: (isosorbide dinitrate: 18 pts, diltiazem or nifedipine: 12
pts, and propranolol or metoprolol: 14 pts). AEM was performed before and
after 2 week treatment.
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Resu/fs: Beta-bl~kers significantly decreased LF/HF and increased HF,
and the degree of increase in HF (AHF) was significantly correlated with
the reduction of ischemic attacks (Fig. 1). Also, beta-blockers abolished
the morning peak of ischemic attacks, which was significantly related to
suppression of LF/HF (Fig. 2). Nitrates and Ca-antagonists did not change
any HRV parameters. Conclusion: Not only suppressed sympathetic tone
but also augmented vagal tone may contribute to the antianginal effect of
beta-blockers.
H980148 Effects of Various Antianglnal Agents on HeartRate Variability in Patients with Silent Myocardial
Ischemia
B. Takase, H. Hikita, A. Uehata, T. Nagai, K. Isojima, A. Kurita,
H. Nakamura. SalfDefense Force CarrtralHospital, Tokyo,Japan, National
Defense Medical Co//ege, Saitanra, Japan
Heart rate variability indices (HRV) and silent myocardial ischemic episodes
(SMI) can be used fo{ prognostication of ischemic heart disease. To investi-
gate the comparative effects of nipredilol (NP), certeolol (CL), diltiezem (DL)
and bepridil (BP) on HRV and SMI, 59 patients (pts) with chronic stable
angina underwent exercise treadmill testing (ETT) and 24 h ambulatory ECG
monitoring (AECG) before (Pre) and after (Pst) medications; fl-adrenergic
blockers of NP (6 mg, ISA –) and CL (15 mg, ISA +) while calcium channel
blockers of DL (90 mg) and BP (150 mg). BP has an additional class l-like
antiarrhythmic action. All pts had SMI ? 1 (1 z- mm, 1 z rein, J 60 ms) in
AECG. A single blind, 2-week placebo-controlled design was utilized, and
pts were randomly allocated to each treatment arm; 16 pte (62 * 8 years) in
NP, 16 pts (61 * 8 years) in CL, 15 pts (56 *6) in DL and 12 pts (66 + 9
yeara) in BP. HRV from AECG included mean RR interval (RR, ins), SDANN
(ins), SD (ins), rMSSD (ins), pNN50 (%) and frequency analysis of heati rate
spectrum resulted in low (L, ms, 0.04-0.15 Hz) and high (H, ms, 0.15-0.40
Hz) frequency components. Results in table (Pre/Pst; SMI, rI/24 h, median;
others, mean; *, p <0.05 vs Pre).
EIT time(s) SMI RR SDANN SD rMSSD PNN50 L H
NP 394/429” 2/0’ S14/950” 119/123 42/49” 21/27* 4i7* 14/1s slln*
CL 4291459” 2/0” S15/S40” 117/ S1 43/40 23122
. . .
5/4 16/15 9/ 9
DL 397/425” 2/0” S79/929” 140/139 46/47 23/27 516 15/15 9/10
BP 4571527’ 2/0” S761964’ 140/133 49/50 24/30 5i7 16/16 91;;
All medications ameliorated ETT results and SMI and increased RR
in AECG, whereas only NP increased HRV. Conclusion: Effects on HRV
were different among antianginal agents even if anti-ischemic effects were
identical. This should be considered in clinical practice.
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D981 137 AutomaticandEfficientR-WaveandP-WaveDiscriminationin RightAtriumUsinga Two-state
HiddenMarkovModel
W. Sun 1,H. Theres2, W, Combs 1, E. Panken 1, P. Fotuhi2, K. Stang12,
G. Baumann2. 1Medtronic, hrc., A4inneapo/is,Minnesota, USA, 2 Cfrarfte
Hospital, Berlin, Germany
Background: The current technique used in implantable devices of adjusting
atrial refractoV and atrial sensitivifyto discriminate between far field R-waves
(FFRW) and P-waves is limited. Reliable detection or rejection of FFRW in
atrial electrograms would avoid some causes of inappropriate atrial sensing,
thus improving DDD sensing and atrial arrhythmia detection. In addition, de-
tection of FFRWSmay be used as a measure for AV conduction time in atriai
tracking modes and allow discrimination of supra-ventricular tachyarrhythmia
from ventricular tachyarrhythmia in ICD patients. Study Gee/: Evaluate anew
technique - two-state hidden Markov model for R- and P-wave discrimina-
tion in atrium. Methods: Atrial and ventricular unipolar electrograms were
collected from 25 patients undergoing pacemaker implant or replacement.
Approximately 5 minutes of intrinsic electrograms were recorded and poet-
analyzed. A new two-state hidden Markov model was developed specifically
for FFRW and P-wave discrimination in the atrium. The recorded patients’
electrograms were analyzed using this model and the sensitivity and poaitive
predictivity of FFRW detection were evaluated. The collected atrial electm-
grams were visually examined and marked as the control for verification of
the detection analysis. Hesulta: FFRW detection using this model had an
overall sensitivity of 94.2 (4c 9.4)~o and a positive predictivity of 96.3 (~
4.4)%. While FFRWrejection using the same model had a sensitivity of 96.8
(4z3.8)% and a positive predictivelyof 99.1 (* 1.7)%. Conclusions: FFRW
and P-wave discrimination in right atrium by the two-state Hidden Markov
model is reliable and accurate, and can significantly improve atrial arrhythmia
management for pacemaker patients.
1981-1381 PredictionofAtrialFibri!lationl%llOVifing
PacemakerImplantation:Useof the
ElectrophysiologicalEvaluation
Y. Inoue, O. Igawa, A. Tomokuni, M. Sawaguchi, T. Suga, M. Adachi,
J. Miake, S. Fujita, 1.Hisadome, C. Shigemasa. Tottori Univereiiy Yonago,
Japan
Previous studies have concluded that non-physiological pacing (VW) more
often promotes the development of atrial fibrillation (AF) than does physio-
logical pacing (AA1/DDD).However, it remains unclear whether the electro-
physiological (EP) parameters offer any additional predictive value. Methods:
Thirly-eight patients (19 males and 19 females, mean age 68 t 11(mean +C
S.D.) years) with sick sinus syndrome (SSS) complicated with the paroxys-
mal atrial fibrillation (AF) were studied. We evaluated their atrial vulnerability
by the EP examination. We defined that if the patients had repetitive atrial
firing (RAF) or fractionated atrial activation (FAA) in the EP examination, their
atrial vulnerability was positive (VULP), and if they had not both response,
their atrial vulnerability was negative (VULn). After the EP evaluation, 11
patients were treated with VW pacing and 27 were treated with DDD/AAl.
None of the patients received any class I or Ill antiarrhythmic drugs. Re-
suks: The mean follow-up period was 2.9 + 1.8 years. Overall, AF was
documented in 17 patients (45%). The lowest incidence of AF was found
in the VULn patients with DDD/AAl (19% vs. 64Y0, O.R. 7.6, p c 0.01).
Considering other predictive factors (age, heart failure, structural heart dis-
ease), the EP evaluation was the most important predictor for the recurrence
of AF in the patients with DDD/AAl (sensitivity 70Y0and specificity 77%.
